Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Transfusion Support.

Schrezenmeier H, Körper S, Höchsmann B, Weinstock C.

In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 23.

2.

Human Leucocyte Antigen Sensitisation and Its Impact on Transfusion Practice.

Weinstock C, Schnaidt M.

Transfus Med Hemother. 2019 Oct;46(5):356-369. doi: 10.1159/000502158. Epub 2019 Aug 29. Review.

3.

Reply to H. McLeod et al.

Weinstock C, Fernandes LL, Theoret M, Tang S, Sridhara R, Beaver JA, Pazdur R.

J Clin Oncol. 2020 Jan 1;38(1):106. doi: 10.1200/JCO.19.02429. Epub 2019 Nov 1. No abstract available.

PMID:
31675249
4.

Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.

Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, Sandler H, Schlegel PN, Song D, Goldberg K, Pazdur R, Beaver JA.

J Urol. 2020 Jan;203(1):115-119. doi: 10.1097/JU.0000000000000532. Epub 2019 Sep 10.

PMID:
31502940
5.

Different Levels of Incomplete Terminal Pathway Inhibition by Eculizumab and the Clinical Response of PNH Patients.

Harder MJ, Höchsmann B, Dopler A, Anliker M, Weinstock C, Skerra A, Simmet T, Schrezenmeier H, Schmidt CQ.

Front Immunol. 2019 Jul 18;10:1639. doi: 10.3389/fimmu.2019.01639. eCollection 2019.

6.

Using a Benefit-Risk Analysis Approach to Capture Regulatory Decision Making: Renal Cell Carcinoma.

Raju GK, Gurumurthi K, Domike R, Singh H, Weinstock C, Kluetz P, Pazdur R, Woodcock J.

Clin Pharmacol Ther. 2020 Mar;107(3):495-506. doi: 10.1002/cpt.1589. Epub 2019 Sep 27.

PMID:
31355920
7.

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody.

Maher VE, Fernandes LL, Weinstock C, Tang S, Agarwal S, Brave M, Ning YM, Singh H, Suzman D, Xu J, Goldberg KB, Sridhara R, Ibrahim A, Theoret M, Beaver JA, Pazdur R.

J Clin Oncol. 2019 Oct 20;37(30):2730-2737. doi: 10.1200/JCO.19.00318. Epub 2019 May 22.

PMID:
31116675
8.

An update on the CD59 blood group system.

Weinstock C, Anliker M, von Zabern I.

Immunohematology. 2019 Jan;35(1):7-8.

PMID:
30908070
9.

A novel allele of the atypical chemokine receptor 1 (ACKR1) gene containing the nucleotide change c.126 T>G (p.42Glu) encodes a third Duffy blood group protein sequence antithetical to that encoding Fya and Fyb antigens.

Weinstock C, Mytilineos J, Bugert P, Sitzmann N, Pensel E, Schrezenmeier H, Fürst D.

Transfusion. 2019 Jun;59(6):2158-2159. doi: 10.1111/trf.15232. Epub 2019 Mar 8. No abstract available.

PMID:
30848497
10.

Evaluation of the New Lateral Flow Card MDmulticard® Basic Extended Phenotype in Routine Clinical Practice.

Mayer B, Müller J, Candela-García MJ, Manteau AC, Weinstock C, Pruß A.

Transfus Med Hemother. 2018 Oct;45(5):341-346. doi: 10.1159/000486606. Epub 2018 Mar 9.

11.

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings.

Storry JR, Clausen FB, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Yanli J, Keller M, Lomas-Francis C, Nogues N, Olsson ML, Peyrard T, van der Schoot E, Tani Y, Thornton N, Wagner F, Weinstock C, Wendel S, Westhoff C, Yahalom V.

Vox Sang. 2019 Jan;114(1):95-102. doi: 10.1111/vox.12717. Epub 2018 Nov 12.

12.

Complement activation by human red blood cell antibodies: hemolytic potential of antibodies and efficacy of complement inhibitors assessed by a sensitive flow cytometric assay.

Anliker M, Schmidt CQ, Harder MJ, Ganchev G, von Zabern I, Höchsmann B, Schrezenmeier H, Weinstock C.

Transfusion. 2018 Dec;58(12):2992-3002. doi: 10.1111/trf.14893. Epub 2018 Oct 27.

PMID:
30367826
13.

Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation.

Schuetz C, Hoenig M, Moshous D, Weinstock C, Castelle M, Bendavid M, Shimano K, Tolbert V, Schulz AS, Dvorak CC.

Blood Adv. 2018 Oct 9;2(19):2550-2553. doi: 10.1182/bloodadvances.2018020883.

14.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.

Flegel WA, Chen Q, Castilho L, Keller MA, Klapper EB, Lane WJ, Pirenne F, Stack G, St-Louis M, Tormey CA, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2018 Sep;16(5):447-456. doi: 10.2450/2018.0260-17. Epub 2018 Feb 14. No abstract available.

15.

U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.

Weinstock C, Khozin S, Suzman D, Zhang L, Tang S, Wahby S, Goldberg KB, Kim G, Pazdur R.

Clin Cancer Res. 2017 Aug 15;23(16):4534-4539. doi: 10.1158/1078-0432.CCR-17-0540. Epub 2017 Jun 13.

16.

A case of anti-Rd causing fetal anemia.

Rauch S, Ritgen J, Wißkirchen M, Bauerfeind U, Kohne E, Weinstock C.

Transfusion. 2017 Jun;57(6):1485-1487. doi: 10.1111/trf.14078. Epub 2017 Mar 7.

PMID:
28267201
17.

Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.

Harder MJ, Kuhn N, Schrezenmeier H, Höchsmann B, von Zabern I, Weinstock C, Simmet T, Ricklin D, Lambris JD, Skerra A, Anliker M, Schmidt CQ.

Blood. 2017 Feb 23;129(8):970-980. doi: 10.1182/blood-2016-08-732800. Epub 2016 Dec 27.

18.

Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer.

Khozin S, Weinstock C, Blumenthal GM, Cheng J, He K, Zhuang L, Zhao H, Charlab R, Fan I, Keegan P, Pazdur R.

Clin Cancer Res. 2017 May 1;23(9):2131-2135. doi: 10.1158/1078-0432.CCR-16-1773. Epub 2016 Dec 6.

19.

Rare donor programs in Switzerland, Germany, and Austria.

Hustinx H, Lejon Crottet S, Scharberg EA, Weinstock C.

Immunohematology. 2016 Jun;32(2):63-66. Review. No abstract available.

PMID:
27901571
20.

CD59: A long-known complement inhibitor has advanced to a blood group system.

Weinstock C, Anliker M, von Zabern I.

Immunohematology. 2015;31(4):145-51.

PMID:
27187193
21.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014.

Flegel WA, De Castilho SL, Keller MA, Klapper EB, Moulds JM, Noizat-Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2016 Sep;14(5):425-33. doi: 10.2450/2015.0130-15. Epub 2015 Dec 21. No abstract available.

22.

Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors.

Weinstock C, Campassi C, Goloubeva O, Wooten K, Kesmodel S, Bellevance E, Feigenberg S, Ioffe O, Tkaczuk KH.

Springerplus. 2015 Aug 28;4:459. doi: 10.1186/s40064-015-1158-5. eCollection 2015.

23.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.

Flegel WA, Castilho L, Delaney M, Klapper EB, Moulds JM, Noizat-Pirenne F, Shehata N, Stack G, Tormey CA, Wagner FF, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2015 Jul;13(3):514-20. doi: 10.2450/2014.0213-14. Epub 2014 Dec 2. No abstract available.

24.

Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.

Weinstock C, Möhle R, Dorn C, Weisel K, Höchsmann B, Schrezenmeier H, Kanz L.

Transfusion. 2015 Mar;55(3):605-10. doi: 10.1111/trf.12882. Epub 2014 Sep 23.

PMID:
25251967
25.

A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient.

Anliker M, von Zabern I, Höchsmann B, Kyrieleis H, Dohna-Schwake C, Flegel WA, Schrezenmeier H, Weinstock C.

Transfusion. 2014 Jul;54(7):1817-22. doi: 10.1111/trf.12531. Epub 2014 Jan 3.

26.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012.

Flegel WA, Johnson ST, Keller MA, Klapper EB, Khuu HM, Moulds JM, Seltsam AW, Stack G, St-Louis M, Tormey CA, Wagner FF, Weinstock C, Yazer MH, Denomme GA.

Blood Transfus. 2014 Apr;12(2):280-6. doi: 10.2450/2013.0022-13. Epub 2013 Oct 18. No abstract available.

27.

HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III.

Flesch BK, Matheis N, Alt T, Weinstock C, Bux J, Kahaly GJ.

J Clin Endocrinol Metab. 2014 Jan;99(1):E177-82. doi: 10.1210/jc.2013-2852. Epub 2013 Dec 20.

PMID:
24187405
28.

It is worthwhile filling in the remaining blank spots for blood group antigen frequencies.

Weinstock C.

Blood Transfus. 2014 Jan;12(1):3-6. doi: 10.2450/2013.0192-13. Epub 2013 Oct 3. No abstract available.

29.

The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera.

Weinstock C, Schnaidt M.

Int J Immunogenet. 2013 Jun;40(3):171-7. doi: 10.1111/j.1744-313X.2012.01147.x. Epub 2012 Aug 23. Review.

PMID:
22913810
30.

Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis.

Weinstock C, Bigenwald R, Hochman T, Sun P, Narod SA, Warner E.

Curr Oncol. 2012 Jun;19(3):e160-4. doi: 10.3747/co.19.890.

31.

HLA antibody specification using single-antigen beads--a technical solution for the prozone effect.

Schnaidt M, Weinstock C, Jurisic M, Schmid-Horch B, Ender A, Wernet D.

Transplantation. 2011 Sep 15;92(5):510-5. doi: 10.1097/TP.0b013e31822872dd.

PMID:
21869744
32.

Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type 1 diabetes.

Weinstock C, Matheis N, Barkia S, Haager MC, Janson A, Marković A, Bux J, Kahaly GJ.

Tissue Antigens. 2011 Apr;77(4):317-24. doi: 10.1111/j.1399-0039.2011.01634.x.

PMID:
21388354
33.

Effect of serum and CTL on focal growth of human cytomegalovirus.

Sinzger C, Mangin M, Weinstock C, Topp MS, Hebart H, Einsele H, Jahn G.

J Clin Virol. 2007 Feb;38(2):112-9. Epub 2007 Jan 3.

PMID:
17204454
35.

Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes.

Lang PA, Kaiser S, Myssina S, Birka C, Weinstock C, Northoff H, Wieder T, Lang F, Huber SM.

Cell Microbiol. 2004 Apr;6(4):391-400.

PMID:
15009030
36.

Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors.

Lang P, Bader P, Schumm M, Feuchtinger T, Einsele H, Führer M, Weinstock C, Handgretinger R, Kuci S, Martin D, Niethammer D, Greil J.

Br J Haematol. 2004 Jan;124(1):72-9.

PMID:
14675410
37.

Endocrine alterations in the aging male.

Elmlinger MW, Dengler T, Weinstock C, Kuehnel W.

Clin Chem Lab Med. 2003 Jul;41(7):934-41.

PMID:
12940521
38.

Upper respiratory tract infection in athletes: influence of lifestyle, type of sport, training effort, and immunostimulant intake.

König D, Grathwohl D, Weinstock C, Northoff H, Berg A.

Exerc Immunol Rev. 2000;6:102-20. Review.

PMID:
10919064
39.

HSP expression in human leukocytes is modulated by endurance exercise.

Fehrenbach E, Passek F, Niess AM, Pohla H, Weinstock C, Dickhuth HH, Northoff H.

Med Sci Sports Exerc. 2000 Mar;32(3):592-600.

PMID:
10731000
40.

Similarities and differences of the immune response to exercise and trauma: the IFN-gamma concept.

Northoff H, Berg A, Weinstock C.

Can J Physiol Pharmacol. 1998 May;76(5):497-504. Review.

PMID:
9839075
41.

Zinc, iron, and magnesium status in athletes--influence on the regulation of exercise-induced stress and immune function.

König D, Weinstock C, Keul J, Northoff H, Berg A.

Exerc Immunol Rev. 1998;4:2-21. Review.

PMID:
9644092
42.

Impaired production of cytokines in a case of human leishmaniasis.

Weinstock C, Knobloch J, Schultheis W, Northoff H.

Clin Infect Dis. 1997 Dec;25(6):1334-9.

PMID:
9431372
43.

Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153.

Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E.

J Biol Chem. 1997 Aug 29;272(35):22173-81.

44.

Effect of exhaustive exercise stress on the cytokine response.

Weinstock C, König D, Harnischmacher R, Keul J, Berg A, Northoff H.

Med Sci Sports Exerc. 1997 Mar;29(3):345-54.

PMID:
9139173
45.

Essential fatty acids, immune function, and exercise.

König D, Berg A, Weinstock C, Keul J, Northoff H.

Exerc Immunol Rev. 1997;3:1-31. Review.

PMID:
9139751
46.

Effect of continuous hemodiafiltration on IL-6, TNF-alpha, C3a, and TCC in patients with SIRS/septic shock using two different membranes.

Braun N, Rosenfeld S, Giolai M, Banzhaf W, Fretschner R, Warth H, Weinstock C, Deppisch R, Erley CM, Müller GA, et al.

Contrib Nephrol. 1995;116:89-98. No abstract available.

PMID:
8529388
47.

The cytokine response to strenuous exercise.

Northoff H, Weinstock C, Berg A.

Int J Sports Med. 1994 Oct;15 Suppl 3:S167-71. Review.

PMID:
7883399
48.

Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.

Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H.

Infect Immun. 1993 Dec;61(12):5140-6.

49.

Production of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the perfused rat liver.

Tran-Thi TA, Weinhold L, Weinstock C, Hoffmann R, Schulze-Specking A, Northoff H, Decker K.

Eur Cytokine Netw. 1993 Sep-Oct;4(5):363-70.

PMID:
8117938
50.

The role of lipoproteins in the inactivation of endotoxin by serum.

Northoff H, Flegel WA, Yurttas R, Weinstock C.

Infusionsther Transfusionsmed. 1992 Aug;19(4):202-3.

PMID:
1422080

Supplemental Content

Loading ...
Support Center